| Description | GPR39 Human Pre-designed siRNA Set A contains three designed siRNAs for GPR39 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GPR39 siRNA-1: 5 nmol (HPLC) GPR39 siRNA-2: 5 nmol (HPLC) GPR39 siRNA-3: 5 nmol (HPLC) siRNA Negative Control:GPR39 Human Pre-designed siRNA Set A contains three designed siRNAs for GPR39 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GPR39 siRNA-1: 5 nmol (HPLC) GPR39 siRNA-2: 5 nmol (HPLC) GPR39 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Biochemical Test:SDS-PAGE (purity > 80%); Western blot with patient sample.Calculated Isoelectric Point:pH 6.47 | Inquire | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Purity>97% by SDS-PAGE and HPLC analyses.Additional sequence informationFunction N-terminal glycine. Full-length mature chain lacking the signal peptideFunctionHas chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects on endothelial cells in an autocrine Purity>97% by SDS-PAGE and HPLC analyses.Additional sequence informationFunction N-terminal glycine. Full-length mature chain lacking the signal peptideFunctionHas chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects on endothelial cells in an autocrine fashion. In vitro, the processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic activity.Post-translationalN-terminal processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) are produced by proteolytic cleavage after secretion from peripheral blood monocytes... Read More |